FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Major Pharmaceuticals Enalapril Maleate Tablets Recall

Enalapril Maleate Tablets, USP, 5 mg, 100 Tablets (10 x 10) Unit Dose per carton, Rx on…

MAJOR PHARMACEUTICALS · Livonia, MI

Risk level
Class III
Reported by FDA
Aug 1, 2018
Recall ID
D-0980-2018
Check your lot numberHow we source this data

Summary

Major Pharmaceuticals recalled Enalapril Maleate Tablets starting Jun 26, 2018. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0980-2018 on Aug 1, 2018. Reason: Failed Impurities/Degradation Specifications: Sub-recall because this repackaged product was recalled by the manufacturing firm, Wockhardt, due to out-of-specification results for the Enalapril DiKetopiperazine degradation product. Status: Terminated.

Why it was recalled

Failed Impurities/Degradation Specifications: Sub-recall because this repackaged product was recalled by the manufacturing firm, Wockhardt, due to out-of-specification results for the Enalapril DiKetopiperazine degradation product.

Product description

Enalapril Maleate Tablets, USP, 5 mg, 100 Tablets (10 x 10) Unit Dose per carton, Rx only, Manufactured by: Wockhardt Limited, H-14/2, M.I.D.C. Area, Waluj, Aurangabad, Maharashtra, India; Distributed by: Wockhardt USA LLC., 20 Waterview Blvd., Parsippany, NJ 07054; Distributed by: MAJOR Pharmaceuticals, 17177 N Laurel Park Dr., Suite 233, Livonia, MI 48152; NDC 0904-5502-61.

Lot numbers, UPCs & expiration codes

Lot #: T-01082, Exp 08/18; DR10445A, Exp 09/18; DR10443A, Exp 12/18; DR10445B, Exp 03/19; DR10725A, Exp 07/19; DS10024A, DS10040A, Exp 10/19.

Where it was sold

Nationwide in the USA and Puerto Rico.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0980-2018
Classification
Class III
Status
Terminated
Recall initiated
Jun 26, 2018
FDA report date
Aug 1, 2018
Quantity
5,933 cartons
Recall type
Voluntary: Firm initiated
Recalling firm
MAJOR PHARMACEUTICALS

Original FDA data

Every field from FDA enforcement report D-0980-2018, exactly as published.

Show all FDA fields
City
Livonia
State
MI
Status
Terminated
Country
United States
Event ID
80463
Address
17177 N Laurel Park Dr
Code information
Lot #: T-01082, Exp 08/18; DR10445A, Exp 09/18; DR10443A, Exp 12/18; DR10445B, Exp 03/19; DR10725A, Exp 07/19; DS10024A, DS10040A, Exp 10/19.
Postal code
48152-2693
Report date
Aug 1, 2018
Product type
Drugs
Recall number
D-0980-2018
Classification
Class III
Recalling firm
MAJOR PHARMACEUTICALS
Product quantity
5,933 cartons
Termination date
Apr 10, 2019
Reason for recall
Failed Impurities/Degradation Specifications: Sub-recall because this repackaged product was recalled by the manufacturing firm, Wockhardt, due to out-of-specification results for the Enalapril DiKetopiperazine degradation product.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Enalapril Maleate Tablets, USP, 5 mg, 100 Tablets (10 x 10) Unit Dose per carton, Rx only, Manufactured by: Wockhardt Limited, H-14/2, M.I.D.C. Area, Waluj, Aurangabad, Maharashtra, India; Distributed by: Wockhardt USA LLC., 20 Waterview Blvd., Parsippany, NJ 07054; Distributed by: MAJOR Pharmaceuticals, 17177 N Laurel Park Dr., Suite 233, Livonia, MI 48152; NDC 0904-5502-61.
Distribution pattern
Nationwide in the USA and Puerto Rico.
Recall initiation date
Jun 26, 2018
Center classification date
Jul 24, 2018

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0980-2018, published Aug 1, 2018. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls